.
MergerLinks Header Logo

New Deal


Announced

Ceres Acquisition to merge with Parallel in a $1.9bn deal.

Financials

Edit Data
Transaction Value£1,355m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Reverse Takeover

Friendly

United States

Merger

Domestic

cannabis operators

Single Bidder

Medical Supplies

Private

Pending

Private Equity

Acquisition

De-SPAC

Synopsis

Edit

Ceres Acquisition, a SPAC, agreed to merge with Parallel, a multi-state cannabis operator, in a $1.9bn deal. In addition, a group of investors, led by Ceres and Parallel, have committed to participate in the transaction through PIPE of $225m. "We believe Parallel is ideally positioned for its next phase of growth, as we continue to build our presence in strategic markets and invest in innovation, R&D and the customer experience. Today's milestone announcement is a testament to Parallel's impressive growth to date, the strength of our business fundamentals, strong balance sheet, and above all, our unwavering commitment to further developing and enhancing our portfolio of cannabinoid products," William Wrigley Jr., Parallel Chairman and CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US